Design and rationale of the COMPARE-TAVI 2 trial: An all-comers head-to-head comparison of Evolut FX+ and Sapien 3 Ultra Resilia transcatheter heart valves

Authors: Troels Thim, Henrik Nissen, Matti Niemelä et al.

Publication: American Heart Journal

Published: Jul 1, 2026

Source: Crossref

Back to Search View Original Cite This Article